XARELTO (rivaroxaban tablets) in Knee and Hip Replacement Surgery

Transcription

1 XARELTO (rivaroxaban tablets) in Knee and Hip Replacement Surgery Fast Facts: XARELTO is a novel, once-daily, oral anticoagulant recently approved in the United States for the prevention (prophylaxis) of deep vein thrombosis (DVT) which may lead to a pulmonary embolism (PE) in patients undergoing knee or hip replacement surgery. XARELTO is a Factor Xa inhibitor, and works by selectively blocking the blood clotting Factor Xa in the blood clotting cascade to reduce the tendency of blood to form clots. 1 Blood clots form to prevent prolonged bleeding in response to damage to a blood vessel; they act as a plug at the site of the blood vessel injury. Certain surgical procedures may increase the risk of inappropriate activation of the blood clotting cascade that can lead to the formation of potentially fatal blood clots. Venous blood clots (also known as venous thromboembolism, or VTE) are a major health problem, causing approximately 300,000 deaths in the U.S. each year. 2 VTE can take the form of either: o A deep vein thrombosis (DVT): a blood clot in a deep vein (usually in the leg) that partially or totally blocks the flow of blood which may lead to; o A pulmonary embolism (PE): a blood clot in the lungs that can partially or totally block the flow of blood. People at risk of venous blood clots include healthy people undergoing major orthopedic surgery (total knee and hip replacement surgeries). About VTE VTE is a potentially deadly condition caused by abnormal (pathologic) blood clots that form in the veins. VTE includes deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT occurs when blood clots in one of the large, deep veins in the legs. Larger blood clots that substantially block the flow of blood may cause pain and swelling in the affected leg. Other symptoms can include redness and feeling of warmth in the leg. 3 Blood clots that only partially block the flow of blood often produce no symptoms; these asymptomatic episodes account for approximately half of all DVT cases. 4 Studies suggest that approximately 50% of patients with untreated proximal DVT which are specifically in the deep knee or thigh veins will develop symptomatic PE within 3 months. 5 Pulmonary embolism (PE) is a serious, potentially life-threatening complication of DVT. 6 A PE most commonly occurs when part or all of a deep venous clot dislodges from the vein where it originated, and is then carried along with the venous blood flow through the right chamber of the heart and into the pulmonary arterial circulation, where it can partially or completely block a branch of the pulmonary artery. Typically, PE causes shortness of breath, rapid breathing, rapid heart rate, sweating, and chest pain. 7 Some patients cough up blood, while others faint. When PE occurs with large clots, or multiple clots, or when the patient already has preexisting heart or lung disease, the process may be rapidly fatal. 8

2 Healthcare costs associated with venous blood clots Complications associated with VTE and its treatment are frequent and costly. The main drivers of VTE costs are initial and recurrent medical events or their associated complications requiring hospitalization. 9 In the U.S., DVT and PE costs for initial hospitalization average more than $9,800 and $14,000, respectively; rehospitalization costs average more than $11,800 and $14,700, respectively. 9 In light of the high overall costs of treatment, using effective VTE prevention strategies after major orthopedic surgery could reduce the economic burden of VTE. VTE following knee or hip replacement surgery Osteoarthritis is the number one driver for patients to opt for knee or hip replacement surgery, and usually occurs in people over the age of Patients undergoing major orthopedic surgery are at high risk for VTE. In the U.S., more than 800,000 people have hip and knee replacement surgery each year, and the most common preventable complications are venous blood clots. 10,11 With an aging population in the U.S., the demand for hip and knee replacement surgeries is expected to rise by 174% and 673%, respectively, by Venous blood clots occur in 40-60% of patients undergoing orthopedic surgery who do not receive preventive care. 13 The American College of Chest Physicians (ACCP) has recommended extended anticoagulation prophylaxis to help reduce the occurrence of DVT or PE following knee or hip replacement surgery. 13 About XARELTO To date, XARELTO is approved in more than 110 countries worldwide and has been successfully launched by Bayer HealthCare in more than 80 countries including Australia, Canada, China, Mexico and within the European Union for the prevention of VTE in adult patients undergoing elective hip or knee replacement surgery. Janssen Pharmaceuticals, Inc. holds marketing rights for XARELTO in the U.S. Important Safety Information WHAT IS XARELTO? XARELTO (rivaroxaban tablets) is a prescription medicine used to help prevent blood clots from forming in patients after hip or knee replacement surgery. WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT XARELTO? You should take XARELTO exactly as directed by your doctor Do not skip a dose or stop taking XARELTO unless you are advised to do so by your doctor. Stopping may increase your risk of a blood clot

3 If a dose is missed, take XARELTO as soon as possible and continue on the following day, taking XARELTO as directed by your doctor. Do not take two doses at the same time XARELTO can cause bleeding, which can sometimes be serious, even life-threatening. You may find you bruise or bleed more easily while you take it. It might take longer than usual to stop bleeding Alert your doctor right away if you develop any: o Tingling, numbness or muscle weakness, especially in your legs. This is particularly important if you had a procedure called spinal or epidural puncture as part of your anesthesia for your hip or knee replacement surgery. o Unusual bleeding or bruising (bruises that develop without an injury or grow in size) o New bleeding (for example, nose bleeds, bleeding gums, red urine, bright red blood in your stool, coughing up or vomiting blood) o Bleeding that is heavier than usual (for example, from cuts or menstruation) o Dizziness, weakness, or tiredness, all of which could indicate a loss of blood o Pain, swelling, or new fluid leakage in or around the surgical incision WHO SHOULD NOT TAKE XARELTO? Tell your doctor if you have: o Unusual bleeding o Ever had an allergic-type (hypersensitivity) reaction to XARELTO WHAT SHOULD I TELL MY DOCTOR BEFORE OR WHILE TAKING XARELTO? Tell your doctor or dentist about all the medicines you take. o This includes XARELTO, any other prescription and nonprescription medicines, over-thecounter medications, and herbal supplements. Tell your doctor if you: o Have a bleeding disorder or have problems with unusual bleeding o Have any problems with your kidneys or liver

4 o Are pregnant or planning to become pregnant. o Are breast-feeding or are planning to breast-feed WHAT ARE THE POSSIBLE SIDE EFFECTS OF XARELTO? XARELTO may increase your chance of bleeding. This bleeding can sometimes be serious (and even life-threatening) In studies side effects with XARELTO included fluid leakage from a wound, itching, pain in arms or legs, blisters, fainting, and muscle spasm. Discuss any side effects with your doctor. You are also encouraged to report side effects to the FDA: visit or call FDA You may also report side effects to Janssen Pharmaceuticals, Inc. at JANSSEN ( ) This is a summary of important information about XARELTO. If you would like more information, talk with your doctor. Please see full Product Information, or visit

A patient's guide Your clinic's contact details are: Name: Contact number: Contents 2 Why have I been prescribed Xarelto? 2 What is Xarelto? 3 How do I take Xarelto? 3 What should I do if I miss a dose

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets What is the most important information I should know about ELIQUIS? For people taking ELIQUIS for atrial fibrillation: People with atrial fibrillation

A PATIENT S GUIDE TO PULMONARY EMBOLISM TREATMENT This medicine is subject to additional monitoring. This will allow quick identification of new safety information. If you get any side effects, talk to

ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE) Information Leaflet Your Health. Our Priority. Page 2 of 6 What Are Anticoagulants And What Do They Do? This information leaflet has

MEDICATION GUIDE PROCRIT (PROKRIT) (epoetin alfa) Read this Medication Guide: before you start PROCRIT. if you are told by your healthcare provider that there is new information about PROCRIT. if you are

Medication Information (Ri va rox xa - ban) Other names for this medication are: Xarelto What does this medication do? This medication is a blood thinner, also called an anticoagulant. It prevents a blood

What You Need to Know After Deep Vein Thrombosis or Pulmonary Embolism The content provided here is for informational purposes only. It is not intended to diagnose or treat a health problem or disease,

Medication Information (a pix a ban) Other names for this medication are: Eliquis What does this medication do? This medication is a blood thinner, also called an anticoagulant. It prevents a blood clot

Safety Information Card for Xarelto Patients 15mg Simply Protecting More Patients 20mg Simply Protecting More Patients Keep this card with you at all times Present this card to every physician or dentist

Preventing Blood Clots After Hip or Knee Replacement Surgery or Surgery for a Broken Hip A Review of the Research for Adults Is This Information Right for Me? Yes, if: You are considering or planning to

MEDICATION GUIDE XARELTO (zah-rel-toe) (rivaroxaban) Tablets Read this Medication Guide before you start taking XARELTO and each time you get a refill. There may be new information. This Medication Guide

Medication Information (a pix a ban) Other names for this medication are: Eliquis What does this medication do? This medication is a blood thinner, also called an anticoagulant. It prevents a blood clot

December 7, 2015 Real-World Data Confirms Safety and Efficacy Profile of XARELTO, With Shorter Hospital Stays, for the Treatment of Deep Vein Thrombosis XALIA is First Prospective Study to Confirm Benefit

Deep vein thrombosis and being in hospital Exceptional healthcare, personally delivered Deep vein thrombosis is a well defined medical condition that can develop when someone is ill or having an operation.

Dabigatran Information for patients UHN Read this medicine fact sheet to learn about: What this medicine is Why you need to take it What side effects to watch for What is the name of my medicine? Dabigatran

Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast Information for patients Pharmacy Your doctor has prescribed a tablet called rivaroxaban. This leaflet tells you about

UW MEDICINE PATIENT EDUCATION Treatment with Apixaban Eliquis This handout explains the medicine apixaban, a drug that helps prevent blood clots. What is apixaban? Apixaban (brand name Eliquis) is an anticoagulant

Preventing blood clots (Venous Thromboembolism) when you have had a lower limb injury Information for Patients The York Hospital Tel: 01904 631313 Scarborough Hospital Tel: 01723 368111 Working together

News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients

(Za-REL-toe) rivaroxaban Consumer Medicine Information WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Xarelto. It does not contain all the available information. It does not take

ABOUT XARELTO CLINICAL STUDIES FAST FACTS Xarelto (rivaroxaban) is a novel, oral direct Factor Xa inhibitor. On September 30, 2008, the European Commission granted marketing approval for Xarelto for the

Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac

Rivaroxaban for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) This leaflet aims to answer your questions about rivaroxaban that may be prescribed for you when you are diagnosed

Oxford University Hospitals NHS Trust Oxford Anticoagulation & Thrombosis Service Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Information for people with a blood clot (thrombus) What is this

About the RECORD Clinical Trial Program Fast facts RECORD was a global program of four trials in more than 12,500 patients, comparing Xarelto (rivaroxaban) and enoxaparin in the prevention of venous thromboembolism

(Za REL toe) rivaroxaban Consumer Medicine Information WHAT IS IN THIS LEAFLET This leaflet answers some common questions about It does not contain all the available information. It does not take the place

Janssen Pharmaceuticals, Inc., and its development partner, Bayer HealthCare, today announced results from PMSS (Post-Marketing Safety Surveillance) and XANTUS (XARELTO for Prevention of Stroke in Patients

Patient s Guide to Prevention of Blood Clots During Pregnancy: Use of Blood-Thinning A Patient s Guide to Prevention of Blood Clots During Pregnancy: Use of Blood-Thinning Drugs to Prevent Abnormal Blood

Preventing Venous Thromboembolism (VTE) Patient Information Thrombosis Patient Safety Committee What is VTE? VTE is the name given to either a deep vein thrombosis (DVT) or a pulmonary embolism (PE). A

What is warfarin? Warfarin sodium (Coumadin ) is a medication that works as an anti-coagulant. Anti means against and coagulant refers to blood clotting. An anticoagulant helps to prevent clots from forming

Royal United Hospital Bath NHS Trust Information for Patients Preventing blood clots during and after a stay in hospital Healthcare you can Trust What is a Deep Vein Thrombosis (DVT)? A DVT occurs when

Venous Thrombosis and Pulmonary Embolism Treatment with Rivaroxaban Information for patients and families Read this booklet to learn: about venous thrombosis and pulmonary embolism how the medicine Rivaroxaban

What You Need to KnowWhen Taking Anticoagulation Medicine What are anticoagulant medicines? Anticoagulant medicines are a group of medicines that inhibit blood clotting, helping to prevent blood clots.

Oxford University Hospitals NHS Trust Reducing the risk of a blood clot for patients with plaster casts Information for patients page 2 What is this leaflet for? When you have your leg held in a certain

Patient Medication Guide Brochure 1 MEDICATION GUIDE TASIGNA (ta-sig-na) (nilotinib) Capsules Read this Medication Guide before you start taking TASIGNA and each time you get a refill. There may be new

Warfarin Warfarin is a useful medicine that helps many patients and has been used since the 1950s. It can be dangerous when not used correctly or without proper medical attention. This leaflet will help

What is dabigatran (Pradaxa )? Dabigatran is also called Pradaxa Dabigatran is used to reduce the risk of blood clots and stroke in people with an abnormal heart rhythm known as atrial fibrillation, or

Living with a Non-Vitamin K Antagonist Oral Anticoagulant (NOAC) dabigatran (Pradaxa ) rivaroxaban (Xarelto ) apixaban (Eliquis ) Information for patients Produced and made available by the Western Australian

More information The organisations below can provide more information and support for people in hospital who may be at risk of DVT. Leicestershire Partnership NHS Trust is not responsible for the quality

Pradaxa Introduction for New Users Introduction Blood clots frequently happen in people who have diseases of the blood vessels or heart. They may pose a dangerous threat to some people. Blood clots may

DEEP VEIN THROMBOSIS James St.George, M.D., RPVI, RVT, RPhS Originally Published In Florida Times Union March 2014 James St.George, M.D., RPVI, RVT, RPhS Dr. St. George is the Medical Director of St Johns

Preventing blood clots while you are in hospital and after you leave Information for patients Pharmacy Why does blood clot? When we cut ourselves, we bleed. To stop us from bleeding too much, chemicals

2014 Preventing Blood Clots While in the Hospital Preventing Blood Clots While in the Hospital This pamphlet will explain: 1. What blood clots are and how they can happen in your body. 2. What your healthcare

This policy has been developed through review of medical literature, consideration of medical necessity, generally accepted medical practice standards, and approved by the IEHP Pharmacy and Therapeutics

November 6, 2015 Important Global Data from XARELTO EXPLORER Cardiovascular Research Program Highlighted in 17 Presentations at the American Heart Association Scientific Sessions 2015 The EXPLORER program

RIVAROXABAN Consumer Information Rivaroxaban is a medicine that is used to increase the time it takes for blood to clot. It belongs to a class of medicines called anticoagulants, which are sometimes also

Warfarin (Coumadin, Jantoven ) Taking your medication safely Welcome This booklet is designed to provide you with important information about warfarin to help you take this medication safely and effectively.

Position Statement: The Use of VTED Prophylaxis in Foot and Ankle Surgery Position Statement There is currently insufficient data for the (AOFAS) to recommend for or against routine VTED prophylaxis for

MEDICATION GUIDE PRADAXA (pra dax a) (dabigatran etexilate mesylate) capsules Read this Medication Guide before you start taking PRADAXA and each time you get a refill. There may be new information. This

Medication Information (Da big a tran) Other names for this medication Pradax What does this medication do? This medication is a blood thinner, also called an anticoagulant. It prevents a blood clot from

Preventing Blood Clots in Adult Patients Information For Patients 1 This leaflet will give you information on how to reduce the risk of developing blood clots during and after your stay in hospital. If